Batra_1993_Eur.J.Cancer_29A_1302

Reference

Title : Characterisation of muscarinic cholinergic receptors in human ovaries, ovarian tumours and tumour cell lines - Batra_1993_Eur.J.Cancer_29A_1302
Author(s) : Batra S , Popper LD , Iosif CS
Ref : Eur J Cancer , 29A :1302 , 1993
Abstract :

Using [3H]quinuclidinyl benzilate (QNB) as radioligand, muscarinic cholinergic receptor sites in isolated plasma membrane fractions from human ovarian tumours, cultured tumour cells, and normal ovarian tissue were characterised. QNB binding to all preparations, except from poorly differentiated tumour, was specific, saturable, and of high affinity. In contrast to normal ovaries, benign tumours, well differentiated adenocarcinoma and OVCAR-3 cells, the poorly differentiated adenocarcinoma and SKOV-3 cells completely lacked specific QNB binding. The muscarinic receptor densities and the Kd values in preparation from ovaries, receptor-positive tumours and OVCAR-3 cells were similar. QNB binding was strongly inhibited by the classical muscarinic receptor antagonist atropine, but poorly by the agonist carbachol. In contrast to atropine, inhibition by pirenzepine and AF-DX 116 was relatively low. These data suggest that muscarinic receptors in ovaries and ovarian tumours are of m3 type.

PubMedSearch : Batra_1993_Eur.J.Cancer_29A_1302
PubMedID: 8343273

Related information

Citations formats

Batra S, Popper LD, Iosif CS (1993)
Characterisation of muscarinic cholinergic receptors in human ovaries, ovarian tumours and tumour cell lines
Eur J Cancer 29A :1302

Batra S, Popper LD, Iosif CS (1993)
Eur J Cancer 29A :1302